Cite
HARVARD Citation
Nathan, S. et al. (2022). Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis. BMJ open respiratory research. 9 (1), p. . [Online].